Methods: The study was carried out as a quasi-experimental study in the Pediatric Surgery Clinics of a university hospital using the "Pre-Test-Post-Test Model in a Single Group". The sample of the study consisted of all high-risk drugs administered by 24 nurses working in these clinics, taking part in medication and agreeing to take part in the study. Data were collected by the researcher using the Medication Observation Form. The Form was created based on the literature, and by making use of the "10 Correct Rules in Medication" and the Medication Skills Steps in the Double Eye Control Program. In the first step, medication error rates were determined through observation method. In the second step; the Web-Based Double-Eye Control Program, which is a standard drug dose calculation and medication program created by the researchers, was started to be implemented. Medication error rates were determined again through post-intervention observation method. Informed voluntary consent, ethics committee and hospital permissions were obtained for the implementation of the study.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The medications observed were to be in the high-risk drug group for children,
* Volunteering of nurses working in the clinic to participate in the research,
* Nurses working in the clinic should have had proper level of internet usage knowledge to use a web-based program.
Exclusion Criteria:
\-
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial looked at a web-based 'double eye control' program to reduce medication errors — can you explain what that kind of system actually does in practice, and whether anything like it is used in the facility where I receive my care?
2Since this trial has already been completed and was measuring error rates, have the results been published or shared anywhere, and what did they find about whether this approach actually reduced mistakes?
3This study was listed as 'Phase NA,' which usually means it's more of a process or systems study rather than a drug trial — does that mean the findings are more about hospital workflow than about my specific treatment, and how would that affect me as a patient?
4If this type of double-check program isn't already in place where I'm being treated, is there anything I or my caregivers can do to help reduce the risk of medication errors in my own care right now?
5Are there other safety initiatives or medication verification programs already available at this hospital that I should know about, especially compared to what this trial was testing?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Error rates
Timeframe: Between January 2017 and September 2018